Raise Capital
Products
Resources
$40M Reg A+ Deal Aims to Increase Brazil’s Potash Production
October 17, 2022
About Brazil Potash
Brazil Potash is a mineral exploration and development company with a potash mining project located in the state of Amazonas. Although Brazil Potash is in the pre-revenue development stage and has not yet commenced any mining operations, its future operating activities, once commenced, will be focused on the extraction and processing of potash ore from its underground mine and selling and distributing the processed potash in Brazil.
Potash is one of the three main nutrients used to grow food. Its primary role is to strengthen the stem of a plant to make it more robust to drought, temperature swings, and insect bites all of which are becoming more prevalent.
Brazil Potash aims to become a significant domestic source of potash fertilizer in Brazil to alleviate Brazil’s dependence on imported potash and farmer supply-chain risk while supporting economic prosperity and agricultural sustainability in Brazil and food security globally.
The process of creating this fertilizer begins with the extraction of potassium ore from deep underground. The ore is then transported to the surface for processing and when complete, it’s applied by farmers to grow food completing the cycle from the earth back to earth. Using this process, once it has obtained all regulatory approvals, Brazil Potash anticipates providing high-quality fertilizer to Brazilian farmers who supply essential food worldwide creating food security, which is a step towards solving the second UN Sustainable Development Goal.
To further finance its pre-operation activities, Brazil Potash raised $40 million via Equity Crowdfunding pursuant to an offering under Tier 2 of Regulation A.
Self-hosting the capital raise on DealMaker was one of the key elements to making this raise possible, with over thousands of investors in multiple jurisdictions.
Building a Self-Sufficient Brazil
Brazil is one of the world's leading producers of agricultural goods. Consequently, Brazil is a key market for potash producers, since, in order to increase the volume and value of crop yields, frequent and balanced replenishment of nutrients in the soil is needed. Potash is integral to Brazil’s economic success since Brazil generates approximately 27% of its gross domestic product from the agricultural sector.
However, Brazil is heavily reliant on imported potash and imports approximately 95% of its potash needs. Brazil Potash believes that Brazil’s government recognizes that reliance on imported potash is not a tenable long-term solution and that Brazil needs to find ways to increase its domestic production of potassium-bearing fertilizers (Potash).
Brazil Potash had to find a capital-raising solution that would allow them to raise a significant sum to advance the project. DealMaker was the capital-raising platform of choice to kick off this large-scale food security project. Our technology and expertise were instrumental in assisting Brazil Potash to secure the financing they needed.
Why Brazil Potash Chose DealMaker
DealMaker announced the successful close of Brazil Potash's Reg A+ deal, raising about $40 million from thousands of investors in multiple jurisdictions. This achievement underscores DealMaker's position as a leading provider of digital capital raise technology, regulatory compliance, and deal management solutions for the global securities industry.
“Once we knew that we would raise capital via a Reg A+, the decision to go with DealMaker was easy. Their platform allowed us to focus on our project advancement goals and not have leadership mindshare bogged down trying to manage thousands of subscription agreements in multiple jurisdictions for the capital raise.” Matt Simpson, CEO, Brazil Potash Corp.
Raising substantial capital globally primarily from retail investors is relatively new, and AML and KYC are difficult when dealing with multiple jurisdictions. DealMaker has a 92% KYC pass rate, higher than other portal averages (typically around 70-80%). This example of a global Reg A+ raise is a step towards creating a single global capital market.
How DealMaker Responded
Our powerful platform made it easy for investors to search and manipulate data to quickly access all the vital information about Brazil Potash, including key metrics such as producer peer valuations and deal size. The streamlined process helped Brazil Potash reach their capital-raising goals.
The Leader in Global Capital Raises
Working with our reputable and experienced team is an essential component when trying to raise capital for your business in multiple jurisdictions. Our tech allows for a seamless investor experience, gives you the deep analytics and insights to drive and optimize investor behavior, and our superior payments ensure your deal has a maximized conversion rate.
Interested in learning more about how our capital raising solution can help you grow and empower your own investors? Get in touch.
When VCs said no, Monogram turned to retail investors. That decision powered their rise from startup to publicly traded company—and even helped them raise an additional $13M privately after their Nasdaq debut.
The Challenge: Raising Capital on Their Terms
The Challenge: Raising on Their Terms
Monogram Technologies was founded with a bold vision: to revolutionize orthopedic surgery with a robotic joint replacement system using custom 3D-printed joints. The market for this technology is massive—approximately $19.6 billion, with over 1 million knee replacements per year. But it's a capital-intensive, regulation-heavy space—and traditional VCs weren't biting.
Instead of compromising, co-founders Dr. Doug Unis and Ben Sexson went all-in on a different path: retail capital. Why?
- Control and ownership: Not only were they able to raise the capital they needed to grow the business—they did it on their own terms.
- Long-term asset: They wanted to build an army of true believers who wanted to see the company succeed and would continue to reinvest over the years.
- A value-add network: Raising from retail allowed Monogram to amass a waiting list of thousands of patients eager to participate in future trials.
- Aligned incentives: Their mission to improve patient outcomes and build a better future for those struggling with joint pain resonated with retail investors.
The Power of Retail: Monogram's Capital Journey
| Start Date | End Date | Type | Platform | Amount Raised | # Investors |
|---|---|---|---|---|---|
| 3/13/19 | 3/31/20 | A+ | SeedInvest | $14,588,668 | 6,000 |
| 11/16/20 | 1/16/21 | A+ | StartEngine | $2,965,501 | 8,000 |
| 1/17/21 | 2/18/22 | A+ | StartEngine | $23,647,853 | 14,082 |
| 7/15/22 | 3/16/23 | CF | DealMaker | $4,673,000 | 2,249 |
| 3/1/23 | 4/8/23 | A+ | Republic | $232,275 | 120 |
| 3/1/23 | 5/23/23 | A+ | DealMaker | $15,958,364 | 5,198 |
| 5/18/23 | - | Nasdaq listing | |||
| 7/24 | 10/24 | Unit Offering | DealMaker | $12,990,103 | 2,745 |
Monogram Capital Raise Timeline
Monogram's first direct-to-investor raise was a $14.6M round in 2019. Since then, Monogram has raised retail capital six additional times, using Reg A+ as a springboard to a Nasdaq listing in 2023.
Each raise brought in new believers—and more importantly, kept bringing them back. That's the long-term power of retail capital. It's not just one campaign—it's a compounding asset that grows with the business.
$80M+
Raised across seven campaigns
~40,000
Investors championing Monogram's vision
20%
Of each raise came from previous investors
Marketing Excellence
DealMaker Reach provided strategic investor acquisition services, helping Monogram connect with the right audience through high-impact channels.
Premium Publications
Targeted campaigns in premium publications like Morning Brew captured qualified investors
High-Engagement Webinars
Engaging events that generated over $4.3 million in investments
Community Building
Strategic approaches that fostered a loyal shareholder base
Investment Momentum
Innovative approaches that amplified investment momentum
Monogram's Journey to Success
Monogram's journey has been defined by relentless innovation, strategic fundraising, and breakthrough advancements in robotic-assisted joint replacement. From early-stage research to a Nasdaq listing and beyond, Monogram's milestones reflect its evolution into a pioneering force in orthopedic surgery:
- Filed its first patent application in 2017
- Conducted clinical studies at UCLA and University of Nebraska
- Expanded the team with key hires
- Attracted a top-tier advisory board to guide clinical innovations
- Signed their first distribution partnerships
- Made headlines with cutting-edge live demonstrations
- Secured 501(k) FDA clearance for the mBôs surgical system
Nasdaq Debut & Beyond
In May 2023, Monogram Orthopaedics successfully listed on the Nasdaq—a significant milestone offering liquidity and growth opportunities for the company.
For most companies, that would be the end of their story in the private markets. But for Monogram, it was just the beginning of a new chapter.
Public perception says you can't raise privately post-IPO. Monogram proved that wrong.
Defying conventional fundraising norms, Monogram raised an additional $13 million from private investors, powered by DealMaker. This move highlighted the power of a dedicated investor community and provided additional strategic growth capital. Meanwhile, strategic digital marketing for the private offering helped boost the public share price—a win-win for the company and its investors, both public and private.
This was retail capital at its best: strategic, repeatable, and aligned.
One vision. Zero compromises.
This wasn't a one-time raise. It was a multi-year capital strategy.
Retail capital helped Monogram:
- Go from concept to commercialization without relying on VCs
- Retain ownership and control in a high-burn industry
- Build a base of loyal shareholders who invested not once, but over and over again
- Uplist to the Nasdaq, and still keep raising post-IPO
This is what makes retail capital different. It doesn't expire—it compounds. And DealMaker is built to maximize that long-term value.
Ready to Raise Capital on Your Terms?
Whether you're pre-revenue or post-IPO, DealMaker gives you the infrastructure, support, and strategy to raise from the people who believe in you most.
Explore Raising Capital with DealMaker.png)
.png)
Your submission has been received. We will reach out to you via email to schedule a call.
Oops! Something went wrong while submitting the form.